Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Helomics, Empirical Bioscience, IncellDx, More

Helomics Precision Oncology Insights Program

Helomics announced that it has launched its new Precision Oncology Insights platform, which provides a personalized oncology roadmap for oncologists and their patients. Having been acquired by Precision Therapeutics in June, Helomics will offer the platform as a tool to test living tumor tissue from the patient to determine how the tumors respond to drugs. Helomics then integrates the drug response with other genomic and molecular data. The firm's artificial intelligence knowledge base, D-CHIP (Dynamic Clinical Health Insights), then analyzes the data to generate a roadmap that provides additional context to help personalize patient treatment. 


Empirical Bioscience EB Pure Agarose Gel Extraction Kit

Empirical Bioscience has introduced the EB Pure Agarose Gel Extraction Kit, which is designed to isolate small DNA fragments (70 bp to 20 kb) from agarose gel in 15 minutes. The system specifically but reversibly binds DNA or RNA under optimized conditions, allowing proteins and other contaminants to be removed. Empirical claims the process will help guarantee consistent recovery rates in more than 85 percent of cases, while simultaneously removing primer-dimers, primers, nucleotides, proteins, salt, agarose, ethidium bromide, and other impurities. The extracted DNA can be used in most applications including ligations, PCR, sequencing, restriction digestion, or various labeling reactions, the firm said.


IncellDx BioINK PD-L1 CTC Core Kit

IncellDx has launched its BioINK PD-L1 CTC Core Kit, a complete, pre-optimized tool to identify, enumerate, and quantify PD-L1 expression in circulating tumor cells. According to the firm, the kit includes the addition of a separate quantitative control cell cocktail — called OncoTect iO Control Cells — that combines PD-L1 positive epithelial cells, PD-L1 negative epithelial cells, and peripheral blood mononuclear cells. The tool allows labs to assess linearity and lower limits of detection for CTC enumeration with known quantities of cells in a lyophilized standard.

The firm's BioINK technology enables highly sensitive and specific quantification of protein or mRNA expression at a single-cell-by-cell resolution optimized for microfluidic chips. 


For more new products and services, please visit the New Products page on our website.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.